跳至主要内容
临床试验/IRCT138806101743N2
IRCT138806101743N2已完成未知

AC add on to the treatment of refractory obssessive compulsive disorder

Research Center for Behavioral Disorder and Substance Abuse, Hamadan University of Medical Sciences0 个研究点目标入组 72 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Suffering from OCD, taking a therapeutic dose of a SSRI or Clomipramine, at least for 12 weeks, Y_BOSC score of 16 or greater Exclusion criteria: primary diagnosis of psychosis or bipolar mood disorder, substance abuse or dependency, uncontrolled medical condition, having had a pervious trial of Memantine, pregnancy or breast feeding, rising liver enzymes to more than twice of normal range during intervention, presence of epilepsy, presence of suicidal thinking, presence of MDD

排除标准

  • 未提供

研究者

发起方
Research Center for Behavioral Disorder and Substance Abuse, Hamadan University of Medical Sciences

相似试验

AC add on to the treatment of refractory obssessive... | 临床试验